Pooled analysis revealed a significant increase of BIRC5 mRNA in prostate cancers (p < 0.05) and prostate cancer metastases (p < 0.0001) compared to tissues from healthy donors or from adjacent normal prostate tissues combined (=no tumor, Fig. 1B). This evidence concerns the gene BIRC5 and Familial prostate cancer.